#smibugs

Partner Content

Partner Content

12 - 13 November 2018 Iselin, New Jersey www.superbugs-usa.com/press Sponsored by Scynexis

Partner Content

Partner Content

SMi Reports: An exclusive interview with Biomedical Adv

News

Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.